Literature DB >> 15022291

The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.

Andrey Korshunov1, Andrey Golanov, Regina Sycheva, Valery Timirgaz.   

Abstract

BACKGROUND: Ependymomas account for 3-5% of all intracranial malignancies and occur most often in children and young adults. These neoplasms continue to generate considerable controversy with regard to their rational clinical management. It has been shown that the histologic classification of ependymoma is a significant predictor of clinical outcome in patients with ependymoma.
METHODS: Ependymomas from 258 patients who underwent microsurgery at a single institution were evaluated histologically to elucidate the prognostic utility of a recently proposed grading scheme. Pathologic and clinical data then were compared using univariate and multivariate analyses.
RESULTS: Increasing grade of ependymoma malignancy was found to be associated strongly and independently with worse clinical outcomes in terms of both event-free survival and overall survival. The effect of radiotherapy also was found to be related to histologic grade and was more beneficial for patients who had anaplastic ependymomas and had undergone complete tumor removal.
CONCLUSIONS: The application of a uniform diagnostic criteria for grading ependymomas highlighted the key role of tumor histology in clinical outcome in a cohort of patients who were treated in the microsurgical era. The recently proposed grading scheme is likely to be practically useful, reproducible, and clinically applicable. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 15022291     DOI: 10.1002/cncr.20075

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.

Authors:  Matthew Koshy; Shayna Rich; Thomas E Merchant; Usama Mahmood; William F Regine; Young Kwok
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

Review 2.  New insights into childhood ependymomas.

Authors:  Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

3.  Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.

Authors:  C Shu; Q Wang; X Yan; J Wang
Journal:  Clin Transl Oncol       Date:  2018-04-27       Impact factor: 3.405

4.  Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.

Authors:  Rakesh Kumar Gupta; Mehar C Sharma; Vaishali Suri; Aanchal Kakkar; Manmohan Singh; Chitra Sarkar
Journal:  J Neurooncol       Date:  2013-11-01       Impact factor: 4.130

5.  Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Authors:  Elizabeth Vera-Bolanos; Kenneth Aldape; Ying Yuan; Jimin Wu; Khalida Wani; Mary Jo Necesito-Reyes; Howard Colman; Girish Dhall; Frank S Lieberman; Philippe Metellus; Tom Mikkelsen; Antonio Omuro; Sonia Partap; Michael Prados; H Ian Robins; Riccardo Soffietti; Jing Wu; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2014-08-13       Impact factor: 12.300

6.  Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.

Authors:  Philippe Metellus; Jacques Guyotat; Olivier Chinot; Anne Durand; Marylin Barrie; Roch Giorgi; Anne Jouvet; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2010-05-19       Impact factor: 12.300

7.  Immunohistochemical study of CD99 and EMA expression in ependymomas.

Authors:  Soheir Mahfouz; Ahmad Abdel Aziz; Samia M Gabal; Samar el-Sheikh
Journal:  Medscape J Med       Date:  2008-02-19

8.  Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.

Authors:  E Susan Amirian; Terri S Armstrong; Kenneth D Aldape; Mark R Gilbert; Michael E Scheurer
Journal:  Neuroepidemiology       Date:  2012-07-28       Impact factor: 3.282

Review 9.  Classification and controversies in pathology of ependymomas.

Authors:  Catherine Godfraind
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 10.  Surgical management of supratentorial ependymomas.

Authors:  Aabir Chakraborty; William Harkness; Kim Phipps
Journal:  Childs Nerv Syst       Date:  2009-04-09       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.